KEGG: sce:YJR124C
STRING: 4932.YJR124C
Antibody specificity should be validated through multiple approaches:
Western blot analysis using both wild-type strains and YJR124C deletion mutants
Immunoprecipitation followed by mass spectrometry
Comparison of signal between overexpression strains and controls
Peptide competition assays to confirm epitope specificity
As demonstrated in work with other yeast proteins, proper controls are essential for establishing antibody specificity. For example, researchers working with Wor1 protein antibodies used immunoblot analyses with various control strains to unambiguously establish that their antibodies specifically recognized the Wor1 protein .
| Step | Conditions |
|---|---|
| Protein Extraction | Mechanical disruption in lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 1% Triton X-100, protease inhibitors) |
| Protein Quantification | Bradford assay or BCA assay |
| SDS-PAGE | 10% acrylamide gel, load 20-30μg total protein per lane |
| Transfer | Wet transfer to PVDF membrane (100V for 1 hour) |
| Blocking | 5% non-fat milk in TBST, 1 hour at room temperature |
| Primary Antibody | YJR124C antibody (1:1000 dilution) in 5% BSA/TBST, overnight at 4°C |
| Secondary Antibody | HRP-conjugated anti-rabbit/mouse IgG (1:5000) in 5% milk/TBST, 1 hour at room temperature |
| Detection | Enhanced chemiluminescence (ECL) substrate |
When performing Western blot analysis, it's important to include appropriate positive and negative controls. For instance, crude extracts prepared from various strains should be analyzed to confirm antibody specificity, as was done with Wor1 protein antibodies .
When facing contradictory results between ChIP-seq and immunofluorescence experiments, consider the following methodological factors:
Epitope accessibility differences between fixed cells and cross-linked chromatin
Antibody batch variation affecting binding efficiency
Different fixation protocols altering epitope conformation
Background signal levels in different experimental contexts
To resolve these contradictions:
Perform epitope mapping to understand antibody binding regions
Use multiple antibodies targeting different regions of YJR124C
Employ spike-in controls for ChIP-seq normalization
Validate results with orthogonal methods such as CUT&RUN or proximity ligation assays
Similar challenges were encountered in studies of Wor1, where researchers combined ChIP experiments with genetic analysis to resolve seemingly contradictory results and establish where Wor1 was associated with chromatin across the entire genome .
For optimal ChIP results with YJR124C antibody:
| Parameter | Recommended Condition |
|---|---|
| Cross-linking | 1% formaldehyde for 15 minutes at room temperature |
| Quenching | 125mM glycine for 5 minutes |
| Sonication | Optimize to achieve 200-500bp fragments (typically 15-20 cycles of 30s on/30s off) |
| Antibody Amount | 5μg per 100μg chromatin |
| Incubation | Overnight at 4°C with rotation |
| Beads | Protein A/G magnetic beads, pre-blocked with BSA |
| Washes | Low salt, high salt, LiCl, and TE buffers (increasing stringency) |
| Elution | 1% SDS, 0.1M NaHCO₃ at 65°C |
| Reverse Cross-linking | 65°C for 4-6 hours |
When analyzing ChIP data, it's crucial to normalize to input and include appropriate controls such as IgG and positive control regions. This approach has been successfully used to study transcription factor binding in various contexts, including work with Wor1 and other transcriptional regulators .
For detecting low-abundance YJR124C variants:
Implement signal amplification methods such as tyramide signal amplification (TSA)
Use highly sensitive detection systems like Quantum Dots or near-infrared fluorophores
Employ proximity ligation assay (PLA) to increase detection specificity
Consider protein enrichment prior to detection via organelle isolation or affinity purification
Additionally, reducing background through more stringent blocking (overnight at 4°C with 5% BSA supplemented with 5% normal serum matching the secondary antibody host) and extended washing steps (6 x 10 minutes with 0.1% Tween-20 in PBS) significantly improves signal-to-noise ratio.
Similar approaches have been successfully employed in studies detecting low-abundance viral and parasite proteins in complex biological samples .
When studying YJR124C dynamics throughout the cell cycle:
Essential Controls:
Cell cycle synchronization validation (e.g., flow cytometry analysis of DNA content)
Positive controls for each cell cycle phase (established cell cycle markers)
YJR124C knockout/knockdown strains as negative controls
Loading controls appropriate for each cell cycle phase (accounting for potential variations)
Time-course validation using multiple synchronization methods to rule out method-specific artifacts
To detect transient protein-protein interactions with YJR124C:
Use membrane-permeable crosslinkers (e.g., DSP or formaldehyde) prior to cell lysis
Incorporate stabilizing agents in lysis buffers (e.g., glycerol, specific ions)
Optimize detergent concentration to maintain interactions while ensuring efficient extraction
Consider proximity-dependent biotinylation (BioID or TurboID) as an alternative approach
Use rapid immunoprecipitation methods with shortened incubation times
Optimized Co-IP Buffer Composition:
25mM HEPES pH 7.5
150mM NaCl
1mM EDTA
10% glycerol
0.1% NP-40
1mM DTT
Protease and phosphatase inhibitor cocktail
This methodology has been effective in capturing transient protein interactions in various experimental systems, similar to approaches used with antibodies against other regulatory proteins .
When encountering non-specific binding:
Increase blocking stringency (use 5% BSA with 2% normal serum from the secondary antibody species)
Pre-adsorb antibody with cell/tissue lysate from YJR124C knockout organisms
Optimize antibody concentration through titration experiments
Include competitive peptides corresponding to non-specific binding regions
Use monovalent Fab fragments instead of complete IgG to reduce Fc-mediated binding
For Western blots specifically, extended membrane washing (6 x 10 minutes) and inclusion of 0.2% SDS in antibody diluent can significantly reduce non-specific interactions.
These approaches parallel troubleshooting strategies used successfully with other challenging antibodies in research contexts .
| Application | Monoclonal YJR124C Antibody | Polyclonal YJR124C Antibody |
|---|---|---|
| Western Blot | Higher specificity, less sensitive | More sensitive, higher background |
| Immunoprecipitation | Better for single epitope accessibility | Superior for denatured/modified proteins |
| ChIP | Consistent results, potential epitope masking | Better signal, batch variation concerns |
| Flow Cytometry | Cleaner results, narrow detection range | Higher signal, potential cross-reactivity |
| Mass Spec Analysis | Cleaner results, fewer identified interactors | More comprehensive interactome coverage |
Advanced epitope mapping approaches include:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Provides resolution to identify specific binding regions
Maintains protein in native conformation
Reveals structural changes upon antibody binding
X-ray Crystallography or Cryo-EM:
Offers atomic-level resolution of antibody-antigen complexes
Requires significant protein quantities and optimization
Phage Display with Peptide Libraries:
Cost-effective approach for initial epitope identification
Can be performed with limited antibody quantities
May miss conformational epitopes
Alanine Scanning Mutagenesis:
Systematically identifies critical residues for binding
Provides functional correlation with structural data
Labor-intensive but highly informative
These methodologies have been employed successfully in characterizing therapeutic antibodies and understanding antibody-antigen interactions at the molecular level .
Integrating YJR124C antibodies with CRISPR-Cas9 approaches:
Validation of Genome Editing:
Confirm protein knockout/modification via Western blot
Verify subcellular localization changes of edited proteins
Quantify expression levels in heterozygous versus homozygous edits
Temporal Studies Post-Editing:
Monitor protein depletion kinetics after inducible CRISPR systems activation
Track compensatory protein expression changes
Functional Domains Analysis:
Create domain-specific deletions/mutations and assess antibody epitope accessibility
Correlate structural changes with functional outcomes
Protein-Protein Interaction Networks:
Compare interactomes before and after specific domain modifications
Identify context-dependent interaction partners in different genetic backgrounds
This integrated approach leverages the specificity of both CRISPR genome editing and antibody-based protein detection to provide comprehensive functional insights, similar to methodologies used in studies of various regulatory proteins .
To adapt YJR124C antibodies for single-molecule imaging:
Direct Fluorophore Conjugation:
Use site-specific conjugation methods to maintain antibody functionality
Optimize fluorophore-to-antibody ratio (2-3 fluorophores per antibody typically optimal)
Consider photoactivatable or photoswitchable fluorophores for super-resolution imaging
Antibody Fragment Generation:
Engineer Fab or scFv fragments for improved tissue penetration
Reduce linkage error in super-resolution techniques
Minimize steric hindrance in crowded molecular environments
Nanobody Alternatives:
Develop camelid nanobodies against YJR124C for reduced size (~15 kDa vs ~150 kDa)
Achieve higher labeling density for improved resolution
Enhance accessibility to sterically hindered epitopes
Quantum Dot Conjugation Protocol:
Conjugate antibodies to quantum dots for extended imaging periods
Implement appropriate controls to account for quantum dot blinking
Optimize quantum dot size to minimize impact on antibody diffusion
These approaches have been successfully implemented for single-molecule tracking studies of various proteins and could be adapted for YJR124C research .
When developing structure-based immunogens for improved YJR124C antibodies:
Computational Epitope Prediction:
Utilize AlphaFold2 or similar tools to predict YJR124C structure
Identify surface-exposed regions with high antigenicity
Design stabilized conformations of immunogenic epitopes
Protein Engineering Approaches:
Incorporate structure-stabilizing mutations to lock epitopes in optimal conformations
Design scaffold proteins to present critical epitopes with proper folding
Implement thermostability screening assays to select optimal designs
Adjuvant Selection and Immunization Protocol:
Test multiple adjuvant formulations to optimize immune response
Implement prime-boost strategies with different immunogen forms
Monitor serum responses against both immunogen and native protein
This structure-based approach was successfully employed for malarial antigen Pfs48/45, where engineered antigens achieved >25°C higher thermostability compared with wild-type protein, resulting in 1-2 orders of magnitude superior activity in antibody responses .
For multiplexed detection of YJR124C and interaction partners:
Spectral Unmixing Approaches:
Utilize fluorophores with minimal spectral overlap
Implement linear unmixing algorithms to resolve overlapping signals
Include single-stained controls for accurate spectral signatures
Multiplexed IF Protocol:
Sequential antibody staining with glycine stripping between rounds
Iterative antibody labeling and imaging with signal quenching
Tyramide signal amplification with different fluorophores
Mass Cytometry Adaptation:
Label antibodies with distinct metal isotopes
Achieve higher multiplexing capacity (40+ parameters)
Implement optimized cell preparation protocols for metal labeling
Proximity-Based Detection Systems:
Employ FRET pairs for direct interaction detection
Implement proximity ligation assay for endogenous protein interactions
Use split fluorescent proteins for real-time interaction monitoring
These multiplexed approaches provide comprehensive insights into protein interaction networks and dynamics, similar to methods used to study complex regulatory systems and therapeutic antibody interactions .